Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Nov;97(11):1471-4.
doi: 10.1136/bjophthalmol-2013-303635. Epub 2013 Sep 13.

Quality of life and cancer-related needs in patients with choroidal melanoma

Affiliations
Comparative Study

Quality of life and cancer-related needs in patients with choroidal melanoma

Joshua F Wiley et al. Br J Ophthalmol. 2013 Nov.

Abstract

Aims: To assess quality of life (QoL) indices and their associations with treatment modality, sociodemographics and cancer-related needs in choroidal melanoma patients.

Methods: Patients (N=99) treated at the University of California, Los Angeles, for choroidal melanoma within the prior 5 years (M=2.05) completed questionnaires assessing demographics, cancer-related needs, vision-specific QoL, depressive symptoms and concern about recurrence. Visual acuity, comorbidities, treatment modality (radiotherapy, enucleation) and years since diagnosis were gathered from medical records. Primary analyses were multiple regressions.

Results: Although concern about cancer recurrence was elevated, QoL was better than in other oncology samples and comparable with healthy samples on some outcomes. Enucleation was associated with worse vision-specific QoL, and presence of comorbid diseases was associated with worse vision-specific QoL, depressive symptoms and concern about cancer recurring (all p values<0.05). Patients who experienced at least one stressful life event in the past year (vs no events) reported more depressive symptoms (p<0.01). Report of more unmet cancer needs was associated with worse vision-specific QoL, depressive symptoms and more concern about recurrence (all p values<0.05), uniquely explaining 4%-12% of the variance.

Conclusions: For choroidal melanoma patients, an average of 2 years after treatment, the number of physical comorbidities and unmet cancer needs were the strongest correlates of poorer QoL.

Keywords: cancer; choroid neoplasms; quality of life.

PubMed Disclaimer

References

    1. Damato B. Developments in the management of uveal melanoma. Clinical & Experimental Ophthalmology. 2004;32(6):639–47. - PubMed
    1. Brandberg Y, Kock E, Oskar K, et al. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: A one year follow-up study. Eye. 2000;14(6):839–46. - PubMed
    1. Chabert S, Velikay-Parel M, Zehetmayer M. Influence of uveal melanoma therapy on patients’ quality of life: a psychological study. Acta Ophthalmologica Scandinavica. 2004;82(1):25–31. - PubMed
    1. Collaborative Ocular Melanoma Study-Quality of Life Study Group. Quality of Life After Iodine 125 Brachytherapy vs Enucleation for Choroidal Melanoma: 5-Year Results From the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3. Arch Ophthalmol. 2006;124(2):226–38. - PubMed
    1. Cruickshanks KJ, Fryback DG, Nondahl DM, et al. Treatment Choice and Quality of Life in Patients With Choroidal Melanoma. Arch Ophthalmol. 1999;117(4):461–67. - PubMed

Publication types

MeSH terms